David Capper

44PUBLICATIONS
291CO-AUTHORS
Molecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Cancer diagnosisMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Sep 10, 2026
PTEN homozygous deletion is a negative prognostic factor in tumor treating fields-treated glioblastoma, IDH wildtype patients.

|Aug 19, 2026
Exploring the landscape of targetable alterations in patients with glioblastoma.

|Jul 28, 2026
Time-dependent prognostic value of automated Ki67 assessment and its integration with molecular risk profiling in WHO grade 2 meningioma.

|Jan 22, 2026
The great imitator: clinical, surgical, and molecular insights into diffuse midline gliomas, H3 K27-altered. Illustrative cases.

Jan Hellmeyer, Lennart W Sannwald, Mats L Moskopp

|Aug 31, 2025
cIMPACT-NOW update 11: Proposal on adaptation of diagnostic criteria for IDH- and H3-wildtype diffuse high-grade gliomas and for posterior fossa ependymal tumors.

Pieter Wesseling, David Capper, Guido Reifenberger

|Jun 06, 2025
crossNN is an explainable framework for cross-platform DNA methylation-based classification of tumors.

Dongsheng Yuan, Robin Jugas, Petra Pokorna

Pageof 8

Frequent Collaborators

15 joint publications

Felix Sahm

12 joint publications

Ulrich Schüller

9 joint publications

Andreas von Deimling

7 joint publications

Sebastian Brandner